Nye medlemmer
New company member: Servier Danmark A/S
We are very happy to welcome Servier Danmark A/S as a new member!
Servier Danmark A/S is subsidiary of the French pharmaceutical group, Servier.
Their ambition is clear: to strengthen their leadership position in select therapeutic areas, especially rare cancers. To achieve this, they are focusing their research efforts, leveraging open innovation and AI. Day in, day out, their teams work tirelessly to discover and develop medicines where patient needs are not yet adequately covered.
In order to move to the next level, they drive fresh momentum by concentrating their efforts in key therapeutic areas. In oncology, they aim at developing precision therapies with a transformative clinical benefit for cancer patients’ lives. In neurology, they primarily address specific diseases to respond to the as yet unmet medical needs of patients. Finally, in cardio metabolism, they focus on innovation in life cycle management. They therefore capitalize on their existing medicines and expertise in incremental innovation, in particular by developing single pill combinations, which also encourage patients to adhere to their treatment.
In the Nordics, they have an experienced team based in Copenhagen, Stockholm, and Helsinki.
Find out more via their website here.
We look forward to seeing them at our events soon!
